文献速递技术与安全CT

评估不同扫描仪技术间的CT剂量差异:对新版CMS CT辐射剂量测量指标合规性的影响

Evaluating CT Dose Variation Across Scanner Technologies: Implications for Compliance with New CMS CT Radiation Dose Measure.
PubMed 文献 · Acad Radiol · 2025-04-02

该回顾性分析评估了2023年某四级医院7种扫描仪型号在8种成人检查中的CT剂量差异。头部平扫(N=21654)的CTDIvol中位数为36.1-68.3mGy,不同型号间差异显著。作者结论认为,忽略扫描仪技术的单一剂量基准可能不充分,甚至可能导致扫描仪被移除。

要点

  • 头部平扫CTDIvol中位数在不同扫描仪型号间为36.1-68.3mGy,差异显著。
  • 胸部增强CTDIvol中位数为6.7-16.1mGy,腹部/盆腔增强为8.8-15.2mGy。
  • 作者认为忽略扫描仪技术的单一剂量基准可能不充分,可能导致扫描仪被移除。

核心结论

  • 忽略扫描仪技术的单一剂量基准即使对相似体型患者也可能不充分,可能需移除扫描仪;纳入多种技术的基准可避免医疗成本增加和患者诊疗中断。

研究设计与样本

  • 回顾性分析2023年1月至12月某四级医院CT检查,聚焦中等体型成人(水等效直径:头部16-19cm、颈部18-22cm、躯干29-33cm),评估7种扫描仪型号在8种成人检查中的剂量指标。

诊断标准与关键数值

  • 头部平扫(N=21654):CTDIvol中位数36.1-68.3mGy,DLP中位数704-1307.8mGy·cm;第75百分位CTDIvol 43.1-69.1mGy,DLP 838.2-1378.1mGy·cm。
  • 胸部增强(N=3065):CTDIvol中位数6.7-16.1mGy,DLP中位数263.8-579.7mGy·cm;第75百分位CTDIvol 8.2-19.5mGy,DLP 329-713.7mGy·cm。
  • 腹部/盆腔增强(N=2740):CTDIvol中位数8.8-15.2mGy,DLP中位数429.3-782.1mGy·cm;第75百分位CTDIvol 10-18.5mGy,DLP 533.4-941.5mGy·cm。
  • 第50和第75百分位剂量按检查与扫描仪型号组合计算,并与美国放射学会可达到剂量和诊断参考水平比较。

临床应用与阅片要点

  • 作者认为,将多种扫描仪技术纳入剂量基准可避免医疗成本增加和患者诊疗中断。
  • 作者结论提示,单一剂量基准忽略扫描仪技术可能导致扫描仪被移除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: In 2025, the Centers for Medicare and Medicaid Services introduced a computed tomography (CT) dose measure for pay-for-performance programs. Hospitals employ diverse scanner fleets, but the impact of scanner technologies on dose benchmarking remains unclear. This study evaluates dose variation across scanner models and its benchmarking implications.

MATERIALS AND METHODS: A retrospective analysis examined CT exams from January to December 2023 at a quaternary-care hospital, focusing on median-sized adults (water-equivalent diameter: 16-19cm head, 18-22cm neck, 29-33cm torso). Dose indices from seven scanner models across eight adult exams were evaluated. The 50th and 75th percentile doses were calculated per exam and scanner model combination, compared to American College of Radiology achievable doses and diagnostic reference levels.

RESULTS: Analyzing 34,166 studies, significant dose variations with scanner models emerged. Head without contrast (N=21,654) had median volume CT-dose-index (CTDIvol) of 36.1-68.3mGy and dose-length-product (DLP) 704-1307.8mGy·cm; 75th percentiles were 43.1-69.1mGy and 838.2-1378.1mGy·cm. Chest with contrast (N=3065) showed median CTDIvol of 6.7-16.1mGy and DLP 263.8-579.7mGy·cm; 75th percentiles were 8.2-19.5mGy and 329-713.7mGy·cm. Abdomen/pelvis with contrast (N=2740) had median CTDIvol of 8.8-15.2mGy and DLP 429.3-782.1mGy·cm; 75th percentiles were 10-18.5mGy and 533.4-941.5mGy·cm. While the number of studies was smaller, five other exams also showed large dose variations across scanner models.

CONCLUSION: Single-value dose benchmarks ignoring scanner technology may be inadequate, even for similar-sized patients, potentially requiring scanner removal. Incorporating benchmarks with diverse technologies could prevent increased healthcare costs and patient care disruptions.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Rehani MM, Mataac MT, Li X, et al. Evaluating CT Dose Variation Across Scanner Technologies: Implications for Compliance with New CMS CT Radiation Dose Measure. Acad Radiol. 2025. PMID: 40175202. doi:10.1016/j.acra.2025.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。